Aripiprazole |
Abilify |
Clinical Trial: Study of Aripiprazole in Subjects with Alcoholism
This study is currently recruiting patients.
|
Purpose
The purpose of this clinical research study is to learn whether subjects treated with aripiprazole are able to abstain from alcohol use for a greater number of days than subjects treated with placebo. The safety of using aripiprazole will also be studied.
| Condition | Treatment or Intervention | Phase |
|---|---|---|
| Alcoholism | Drug: Aripiprazole | Phase IV |
MedlinePlus related topics: Alcoholism
Study Type: Interventional
Study Design: Treatment
Official Title: A Phase 4 Study of Aripiprazole in Subjects with Alcoholism
Eligibility
Ages Eligible for Study: 21 Years - 65 Years, Genders Eligible for Study: Both
Criteria
- Subjects with a diagnois of alcohol dependence who want to stop using alcohol will be considered for the study.
Location and Contact Information
Connecticut
Local Institution, Farmington, Connecticut, United States; Recruiting
Local Institution, New Haven, Connecticut, United States; Recruiting
Indiana
Local Institution, Indianapolis, Indiana, United States; Recruiting
Massachusetts
Local Institution, Boston, Massachusetts, United States; Recruiting
New York
Local Institution, Buffalo, New York, United States; Recruiting
Local Institution, New York, New York, United States; Recruiting
Local Institution, Rochester, New York, United States; Recruiting
North Carolina
Local Institution, Chapel Hill, North Carolina, United States; Recruiting
Pennsylvania
Local Institution, Philadelphia, Pennsylvania, United States; Recruiting
Local Institution, Philadelphia, Pennsylvania, United States; Recruiting
Rhode Island
Local Institution, Providence, Rhode Island, United States; Recruiting
South Carolina
Local Institution, Charleston, South Carolina, United States; Recruiting
Texas
Local Institution, Dallas, Texas, United States; Recruiting
Local Institution, Houston, Texas, United States; Recruiting
Local Institution, San Antonio, Texas, United States; Recruiting
Virginia
Local Institution, Charlottesville, Virginia, United States; Not yet recruiting
Wisconsin
Local Institution, Milwaukee, Wisconsin, United States; Recruiting
More Information
Record last reviewed: January 2005
Last Updated: January 24, 2005
Record first received: April 30, 2004
ClinicalTrials.gov Identifier: NCT00082199
Health Authority: United States: Food and Drug Administration
ClinicalTrials.gov processed this record on 2005-04-08
Source: ClinicalTrials.gov
Cache Date: April 9, 2005

Not Signed In -


